Literature DB >> 29562203

Loss of NF-κB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent Manner.

Lorraine A O'Reilly1, Tracy L Putoczki2, Lisa A Mielke2, Jun T Low2, Ann Lin3, Adele Preaudet3, Marco J Herold2, Kelvin Yaprianto4, Lin Tai3, Andrew Kueh2, Guido Pacini3, Richard L Ferrero5, Raffi Gugasyan6, Yifang Hu3, Michael Christie7, Stephen Wilcox2, Raelene Grumont8, Michael D W Griffin9, Liam O'Connor2, Gordon K Smyth10, Mathias Ernst11, Paul Waring12, Steve Gerondakis8, Andreas Strasser13.   

Abstract

Polymorphisms in NFKB1 that diminish its expression have been linked to human inflammatory diseases and increased risk for epithelial cancers. The underlying mechanisms are unknown, and the link is perplexing given that NF-κB signaling reportedly typically exerts pro-tumorigenic activity. Here we have shown that NF-κB1 deficiency, even loss of a single allele, resulted in spontaneous invasive gastric cancer (GC) in mice that mirrored the histopathological progression of human intestinal-type gastric adenocarcinoma. Bone marrow chimeras revealed that NF-κB1 exerted tumor suppressive functions in both epithelial and hematopoietic cells. RNA-seq analysis showed that NF-κB1 deficiency resulted in aberrant JAK-STAT signaling, which dysregulated expression of effectors of inflammation, antigen presentation, and immune checkpoints. Concomitant loss of STAT1 prevented these immune abnormalities and GC development. These findings provide mechanistic insight into how polymorphisms that attenuate NFKB1 expression predispose humans to epithelial cancers, highlighting the pro-tumorigenic activity of STAT1 and identifying targetable vulnerabilities in GC.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29562203     DOI: 10.1016/j.immuni.2018.03.003

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  18 in total

1.  Neutrophils Deficient in Innate Suppressor IRAK-M Enhances Anti-tumor Immune Responses.

Authors:  Yao Zhang; Na Diao; Christina K Lee; Hong Wei Chu; Lan Bai; Liwu Li
Journal:  Mol Ther       Date:  2019-09-23       Impact factor: 11.454

2.  Expression profile and prognostic values of STAT family members in non-small cell lung cancer.

Authors:  Mengqi Yang; Huanting Chen; Lin Zhou; Kai Chen; Fengxi Su
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

3.  Endogenous glucocorticoids prevent gastric metaplasia by suppressing spontaneous inflammation.

Authors:  Jonathan T Busada; Sivapriya Ramamoorthy; Derek W Cain; Xiaojiang Xu; Donald N Cook; John A Cidlowski
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

4.  JAK-STAT1 Signaling Pathway Is an Early Response to Helicobacter pylori Infection and Contributes to Immune Escape and Gastric Carcinogenesis.

Authors:  Xue Li; Kaifeng Pan; Michael Vieth; Markus Gerhard; Wenqing Li; Raquel Mejías-Luque
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

5.  Single-cell transcriptional analyses of spasmolytic polypeptide-expressing metaplasia arising from acute drug injury and chronic inflammation in the stomach.

Authors:  Kevin A Bockerstett; Scott A Lewis; Kyle J Wolf; Christine N Noto; Nicholas M Jackson; Eric L Ford; Tae-Hyuk Ahn; Richard J DiPaolo
Journal:  Gut       Date:  2019-09-03       Impact factor: 23.059

6.  CXCL5 promotes gastric cancer metastasis by inducing epithelial-mesenchymal transition and activating neutrophils.

Authors:  Zheying Mao; Jiahui Zhang; Yinghong Shi; Wei Li; Hui Shi; Runbi Ji; Fei Mao; Hui Qian; Wenrong Xu; Xu Zhang
Journal:  Oncogenesis       Date:  2020-07-06       Impact factor: 7.485

Review 7.  Novel discoveries targeting gemcitabine-based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?

Authors:  Wenhao Luo; Gang Yang; Jiangdong Qiu; Jingyang Luan; Ying Zhang; Lei You; Mengyu Feng; Fangyu Zhao; Yueze Liu; Zhe Cao; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Cancer Med       Date:  2019-09-01       Impact factor: 4.452

Review 8.  NFKB1 and Cancer: Friend or Foe?

Authors:  Julia Concetti; Caroline L Wilson
Journal:  Cells       Date:  2018-09-07       Impact factor: 6.600

9.  Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable Immunodeficiency.

Authors:  Federica Pulvirenti; Antonio Pecoraro; Francesco Cinetto; Cinzia Milito; Michele Valente; Enrico Santangeli; Ludovica Crescenzi; Francesca Rizzo; Stefano Tabolli; Giuseppe Spadaro; Carlo Agostini; Isabella Quinti
Journal:  Front Immunol       Date:  2018-11-05       Impact factor: 7.561

10.  PLXNC1: A Novel Potential Immune-Related Target for Stomach Adenocarcinoma.

Authors:  Zhizhan Ni; Chenshen Huang; Hongmei Zhao; Jinzhe Zhou; Muren Hu; Qing Chen; Bujun Ge; Qi Huang
Journal:  Front Cell Dev Biol       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.